Azithromycin: Dosing, Contraindications, and Alternatives
Azithromycin is a macrolide antibiotic with well-established dosing regimens that vary by indication, age, and infection type, with specific contraindications including hypersensitivity to macrolides and caution required with hepatic impairment and certain drug interactions.
Recommended Dosing Regimens
Adults
For respiratory tract infections (community-acquired pneumonia, acute bacterial sinusitis, pharyngitis/tonsillitis, skin infections): 500 mg on day 1, followed by 250 mg daily on days 2-5 1, 2.
Alternative 3-day regimen for acute bacterial exacerbations of COPD and sinusitis: 500 mg once daily for 3 days 2.
For sexually transmitted infections:
- Non-gonococcal urethritis/cervicitis (Chlamydia): 1 g orally as a single dose 3, 4, 2
- Gonococcal urethritis/cervicitis: 2 g orally as a single dose 2
- Chancroid: 1 g orally as a single dose 2
Pediatric Patients
For pertussis 1:
- Infants <6 months: 10 mg/kg/day for 5 days (preferred over erythromycin due to lower risk of infantile hypertrophic pyloric stenosis)
- Infants and children ≥6 months: 10 mg/kg (max 500 mg) on day 1, then 5 mg/kg/day (max 250 mg) on days 2-5
For community-acquired pneumonia, Mycoplasma, or Chlamydia infections 5, 2:
- IV: 10 mg/kg on days 1 and 2, then transition to oral
- Oral: 10 mg/kg on day 1, followed by 5 mg/kg/day on days 2-5
For acute otitis media 2:
- Single-dose regimen: 30 mg/kg as a single dose
- 3-day regimen: 10 mg/kg once daily for 3 days
- 5-day regimen: 10 mg/kg on day 1, then 5 mg/kg/day on days 2-5
For pharyngitis/tonsillitis 2, 6:
- 12 mg/kg once daily for 5 days (total dose 60 mg/kg provides optimal GABHS eradication)
- Alternative: 20 mg/kg once daily for 3 days (also totaling 60 mg/kg)
For conjunctivitis (Chlamydia) 7:
- Children <8 years weighing >45 kg: 1 g orally, single dose
- Children ≥8 years: 1 g orally, single dose
Critical Contraindications and Precautions
Absolute contraindication: History of hypersensitivity to any macrolide agent 1.
Hepatic impairment: Prescribe with caution; no specific dose adjustment recommendations exist, but monitoring is essential 1, 2.
Renal impairment: No dose adjustment needed for GFR >10 mL/min. Exercise caution with severe renal impairment (GFR <10 mL/min) as AUC increases by 35% 2.
Drug interactions requiring monitoring 1:
- Avoid simultaneous administration with aluminum- or magnesium-containing antacids (reduces absorption)
- Monitor when used with digoxin, triazolam, ergot alkaloids, or drugs metabolized by cytochrome P450
- Unlike erythromycin, azithromycin does NOT require avoidance with astemizole, cisapride, or terfenadine
Pregnancy: FDA Pregnancy Category B 1.
Infants <1 month: Azithromycin is preferred over erythromycin for pertussis due to the association between erythromycin and infantile hypertrophic pyloric stenosis (IHPS). However, monitor all infants receiving macrolides for IHPS symptoms 1.
Alternative Therapies
For Chlamydia/Non-gonococcal Urethritis
First-line alternative: Doxycycline 100 mg orally twice daily for 7 days 3, 4, 8.
Azithromycin should only be used if doxycycline has failed, is contraindicated, or if adherence concerns exist 8. Recent evidence shows azithromycin efficacy for genital chlamydia has decreased from 85.3% before 2009 to 67% since 2009, while doxycycline maintains 100% efficacy 8.
Other alternatives: Erythromycin base 500 mg four times daily for 7 days, ofloxacin 300 mg twice daily for 7 days, or levofloxacin 500 mg once daily for 7 days 4.
For Respiratory Tract Infections (Mycoplasma/Chlamydia pneumonia)
Alternatives 5:
- Clarithromycin 15 mg/kg/day in 2 doses
- Erythromycin 40 mg/kg/day in 4 doses (less preferred due to GI side effects)
- For children >7 years: Doxycycline 2-4 mg/kg/day in 2 doses
- For adolescents with skeletal maturity: Levofloxacin 500 mg once daily or moxifloxacin 400 mg once daily
For Pertussis
If azithromycin unavailable 1:
- Erythromycin 40-50 mg/kg/day in 4 divided doses for 14 days (NOT preferred in infants <1 month due to IHPS risk)
- Clarithromycin: Infants <1 month: 15 mg/kg/day in 2 doses for 7 days; ≥1 month: same dosing
For Pharyngitis/Tonsillitis
First-line: Penicillin V remains the standard therapy for GABHS pharyngitis 6. Azithromycin is reserved for penicillin hypersensitivity, suspected nonadherence, or beta-lactam treatment failure.
Common Pitfalls and Clinical Pearls
Side effects: Primarily gastrointestinal (abdominal pain, diarrhea, nausea, vomiting) but significantly less frequent and severe than erythromycin 1. Headache and dizziness may occur.
Administration: Can be taken with or without food for tablets/capsules 2. Food increases Cmax by 56% for suspension but does not affect AUC 2.
Compliance advantage: The once-daily dosing and short treatment duration (3-5 days for most infections) significantly improve adherence compared to multi-dose, longer-duration regimens 9, 10, 11.
Tissue penetration: Despite low serum concentrations, azithromycin achieves tissue concentrations exceeding those of erythromycin, with concentrations in leukocytes >1000-fold higher than serum 2, 10. This explains efficacy despite lower serum levels.
Resistance concerns: Erythromycin-resistant organisms are also resistant to azithromycin 10. For GABHS pharyngitis, bacteriologic failures up to 35% have been documented with penicillin, making azithromycin a reasonable alternative when using the 60 mg/kg total dose regimen 6.
Dispensing recommendation: Medications should be dispensed on-site with the first dose directly observed to maximize compliance 4.